Astrana is latest U.S. healthcare company to face acyberattack

Astrana Health ASTH fell 7% premarket after reporting a 'material' cybersecurity incident at its subsidiary, Astrana Health Management. The breach involved unauthorized access to private/confidential data via social engineering. The company is investigating and stated the incident won't materially impact its financials, as of Sept. 22.

Original reporting
Published Sep 23, 2026, 1:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 1:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Astrana is latest U.S. healthcare company to face acyberattack — source image
Decision brief

The 30-second read

$ASTHBearishMed
01

Why it matters

The breach is material, prompting a notable pre‑market sell‑off and heightened risk perception.

02

Market read

The incident drives immediate negative sentiment and may influence broader healthcare sector risk assessments.

03

What to watch

Potential insurance coverage and limited operational disruption.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

Astrana Health is a U.S. healthcare services platform; cyber incidents can affect patient data and regulatory compliance.

Company-level read

Ticker impact

$ASTHBearishHigh confidence
Context

Astrana Health reported a material cyberattack causing a >7% pre‑market drop.

Expected impact

Potential further decline of 3‑5% intraday before stabilization.

Evidence & confidence

First‑report breach, material incident, and immediate price reaction indicate heightened risk.

Market effects

Raises cybersecurity concerns for U.S. healthcare providers.

May pressure other health‑tech stocks in the U.S. market.

Limited to U.S. healthcare sector.

Counterpoint

If breach impact is contained, the stock could rebound quickly.

Key entities

  • Astrana Health

    U.S. healthcare services platform reporting the breach.

Related articles

$ASTHHighAI 8/10

Astrana Health Earnings Call Highlights Growth and Deleveraging

Astrana Health (ASTH) reported Q3 revenue of $1.02B (+7% YoY) and adjusted EBITDA of $77.2M (+13% YoY). The company highlighted organic growth, debt reduction, and favorable Medicare trends. Management maintained full-year guidance, expecting revenue of $3.9B-$4B and adjusted EBITDA of $261M-$274M. Challenges include Medicaid pressure and seasonality.

$ASTHMed

Astrana Health 3Q 2026: Revenue $1.02B, EPS $0.26 — 10-Q Summary

Astrana Health reported 3Q 2026 revenue of $1.02B, up 7% YoY, and net income of $13.0M, compared to $373K last year. Growth was driven by 9% increase in capitation revenue. Care Partners saw 8% revenue growth and 94% operating income rise, while Care Delivery revenue increased 5% but operating loss widened. Care Enablement revenue rose 5% with 4% higher operating income. Astrana managed 29 IPAs and 1.5M patients as of September 30, 2026.

$ASTHMed

Astrana Health Inc (ASTH) (Q3 2026) Earnings Call Highlights: Record Revenue and EBITDA

Astrana Health Inc (ASTH) reported Q3 2026 earnings, highlighting record revenue and EBITDA growth. CEO Brandon Sim discussed Medicaid membership attrition, Medicare Advantage dynamics, and care enablement business momentum. The company expects mid-teens EBITDA growth despite Medicaid headwinds. A cybersecurity incident is under investigation, and a new 'premiums at risk' disclosure was introduced for ACO business transparency.

$ASTHHighAI 8/10

Astrana Health (ASTH) Q3 2026 Earnings Call Transcript

Astrana Health (ASTH) reported Q3 2026 revenue of $1.02B (+7% YoY) and adjusted EBITDA of $77.2M (+13% YoY). Membership grew to 1.5M, with Medicare Advantage increasing organically. The company completed acquisitions and partnerships, expanding its presence. Medical cost trends were slightly better than expected, with Texas operations performing ahead of plan. Free cash flow reached $105M, and net leverage was reduced to 2.2x.

$ASTHMed

Astrana Health Q3 Earnings Call Highlights

Astrana Health reported 1.5 million members under management, with Medicare Advantage growth offsetting Medicaid attrition. The company expects Medicaid membership to decline 10-15% in 2027, impacting adjusted EBITDA. Medical cost trends were slightly better than expected, with Medicare Advantage margins stable. Astrana plans 82% of capitation revenue from full-risk arrangements by 2026 and completed acquisitions and partnerships.